5.6 KiB
| type | title | author | url | date | domain | secondary_domains | format | status | priority | tags | processed_by | processed_date | extraction_model | extraction_notes | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| source | AHA Scientific Statement: Food Is Medicine RCTs for Noncommunicable Disease — Inconsistent Clinical Outcomes | American Heart Association (multiple authors) | https://www.ahajournals.org/doi/10.1161/CIR.0000000000001343 | 2025-01-01 | health | systematic-review | null-result | high |
|
vida | 2026-03-18 | anthropic/claude-sonnet-4.5 | LLM returned 1 claims, 1 rejected by validator |
Content
AHA Scientific Statement published in Circulation reviewing 14 US randomized controlled trials of Food Is Medicine interventions for noncommunicable disease.
Scope: FIM interventions including MTMs, produce prescriptions, medically tailored groceries, food pharmacies. Focused on US RCTs only.
Primary finding:
- FIM interventions "often positively influence diet quality and food security" — consistent positive finding across intervention types
- "Impact on clinical outcomes was inconsistent and often failed to reach statistical significance"
- Specific outcomes reviewed: HbA1c, blood pressure, BMI
- 14 RCTs showed improvements in diet quality and food security; clinical outcomes inconsistent
Evidence quality assessment:
- Most evidence exists for MTMs (most evidence, highest intervention specificity)
- Evidence for produce prescriptions and medically tailored groceries: "remains limited"
- Randomized trials on health outcomes, healthcare utilization, and cost of health care use: ongoing
Context from related searches:
- Recipe4Health (2,643 participants, before-after design): HbA1c -0.37%, non-HDL -17 mg/dL — observational, not RCT
- Multisite evaluation of 9 produce prescription programs: significant improvements in food security and F&V intake; "clinically relevant improvements" in HbA1c for adults with poor baseline cardiometabolic health — ALSO not RCT design
Policy implications stated:
- AHA supports expansion and standardization of FIM programs
- Calls for more rigorous RCTs with standardized outcomes
- Notes evidence is sufficient to support small-scale expansion but not system-wide policy without more controlled evidence
Agent Notes
Why this matters: This is the most authoritative US evidence review of food-as-medicine RCTs. The AHA imprimatur gives it weight, and the finding — "inconsistent and often failed to reach statistical significance" — is directly relevant to whether Belief 2's intervenability claim holds. Coming from AHA (not a skeptical source), this is a meaningful acknowledgment of the clinical evidence gap.
What surprised me: The AHA is simultaneously an advocate for FIM programs (calls for expansion) and acknowledges the RCT evidence is inconsistent. This is not a debunking piece — it's a nuanced "promising but not proven" finding from a credibly pro-intervention source. That makes the inconsistency finding MORE credible, not less.
What I expected but didn't find: A breakdown of which specific intervention types showed clinical effects in RCTs vs. which didn't. The review covers FIM as a category while acknowledging heterogeneity without fully parsing it.
KB connections:
- Directly relates to the food-as-medicine section in the SDOH claim
- Supports the claim candidate from Session 1: "food-as-medicine interventions show inconsistent RCT evidence for clinical outcomes"
- Connects to the AHA June 2024 systematic review on SDOH and cardiovascular outcomes (if that's in the KB)
Extraction hints:
- The key extractable claim: "14 US FIM RCTs show consistent improvements in diet quality and food security but inconsistent and often non-significant effects on HbA1c, blood pressure, and BMI"
- This is a claim about EVIDENCE QUALITY by intervention type, not about whether food matters for health
- Distinguish the diet/food security finding (consistent) from the clinical outcome finding (inconsistent) — they're both important and the KB shouldn't collapse them
Context: The AHA Scientific Statement carries significant policy weight — it's the type of document that CMS and state Medicaid programs cite when making coverage decisions. Its ambiguous conclusion ("promising but inconsistent") reflects the genuine state of the literature.
Curator Notes
PRIMARY CONNECTION: Existing food-as-medicine / SDOH evidence claims in health domain WHY ARCHIVED: Most authoritative US RCT evidence review on FIM clinical outcomes — the canonical source for "what the evidence actually says" EXTRACTION HINT: Extract two claims: (1) FIM consistently improves diet quality and food security (proven); (2) FIM clinical outcomes (HbA1c, BP, BMI) are inconsistent and often non-significant in RCTs (likely). These are different claims that the field conflates.
Key Facts
- AHA Scientific Statement reviewed 14 US randomized controlled trials of Food Is Medicine interventions
- FIM intervention types reviewed: medically tailored meals, produce prescriptions, medically tailored groceries, food pharmacies
- Clinical outcomes assessed: HbA1c, blood pressure, BMI
- Medically tailored meals have the most evidence and highest intervention specificity among FIM types
- AHA supports expansion and standardization of FIM programs despite inconsistent RCT evidence
- Recipe4Health observational study (2,643 participants) showed HbA1c -0.37%, non-HDL -17 mg/dL but was not an RCT
- Multisite evaluation of 9 produce prescription programs showed improvements in food security and F&V intake but was not RCT design